Home › NDC Lookup › Ingredients › Bryonia Alba Root - Causticum - Loeselia... › 17312-0171-14
⚪image loading
(from DailyMed)

Fibromyalgia Relief BRYONIA ALBA ROOT - CAUSTICUM - LOESELIA MEXICANA WHOLE - MAGNESIUM PHOSPHATE - PULSATILLA VULGARIS - TOXICODENDRON PUBESCENS LEAF - VALERIAN 6 [hp_C]/1; 6 [hp_C]/1; 6 [hp_C]/1; 6 [hp_C]/1; 6 [hp_C]/1; 6 [hp_C]/1 Tablet, Orally Disintegrating, 70-count

by TRP Company · 1 BOTTLE in 1 PACKAGE (17312-171-14) / 70 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE
NDC 17312-0171-14
🏷️ FDA NDC (as labeled) 17312-171-14 billing pads the product segment with a zero
OTC On market Non-controlled
🗂️ Data synced Sep 17, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

🆔 Identity & classification

FDA NDC (as labeled) 17312-171-14
Product NDC 17312-171
11-digit billing NDC 17312017114
UNII XA8YCV5M3E, T7J046YI2B, DD5FO1WKFU, HF539G9L3Q, I76KB35JEV, 6IO182RP7A
UPC 0858961001716
SPL Set ID a6ba3058-ec39-715f-e053-2995a90aa32a
Established class (EPC) Calculi Dissolution Agent; Osmotic Activity
Mechanism of action Magnesium Ion Exchange Activity
Physiologic effect Increased Large Intestinal Motility; Inhibition Large Intestine Fluid/Electrolyte Absorption; Inhibition Small Intestine Fluid/Electrolyte Absorption
DEA schedule Non-controlled
Marketing category UNAPPROVED HOMEOPATHIC
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2020-05-28
Route ORAL
Dosage form TABLET, ORALLY DISINTEGRATING
Substance LOESELIA MEXICANA WHOLE; BRYONIA ALBA ROOT; CAUSTICUM; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; PULSATILLA VULGARIS; TOXICODENDRON PUBESCENS LEAF
Why two NDCs? The FDA registers this code as 17312-171-14 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 17312-0171-14. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏭 Manufacturer & labeler

LabelerTRP Company
Labeler code17312
First marketedMay 2020
Product typeHuman Otc Drug
Portfolio31 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

🧪 What is this product?

This is an unapproved homeopathic tablet that dissolves in the mouth. It contains six plant and mineral ingredients (bryonia alba root, causticum, loeselia mexicana, magnesium phosphate, pulsatilla vulgaris, and toxicodendron pubescens leaf) that are used in homeopathic practice. In homeopathic tradition, these substances are employed for conditions involving joint and muscle discomfort. Homeopathic products are marketed based on traditional use and have not been evaluated by the FDA for effectiveness.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Fibromyalgia Relief 6 [hp_C]/1; 6 [hp_C]/1; 6 [hp_C]/1; 6 [hp_C]/1; 6 [hp_C]/1; 6 [hp_C]this 17312-0171-14 TRP 70 tablets — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

⏳ Availability & generic status

🏛️
2020
On the market since
May 2020
📍
2026
Currently FDA-listed
6 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
17312-0171-14 You're viewing this 1 BOTTLE in 1 PACKAGE (17312-171-14) / 70 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE 2020-05-28 Active

🧭 About this NDC listing & data coverage

Over-the-counter (OTC) product Homeopathic listing

About homeopathic listings

Fibromyalgia Relief BRYONIA ALBA ROOT - CAUSTICUM - LOESELIA MEXICANA WHOLE - MAGNESIUM PHOSPHATE - PULSATILLA VULGARIS - TOXICODENDRON PUBESCENS LEAF - VALERIAN 6 [hp_C]/1; 6 [hp_C]/1; 6 [hp_C]/1; 6 [hp_C]/1; 6 [hp_C]/1; 6 [hp_C]/1 TABLET, ORALLY DISINTEGRATING is listed under the homeopathic marketing category. An NDC listing in this category does not by itself establish FDA approval, and FDA does not evaluate homeopathic products for effectiveness. This page reports the listing data as published.

What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Unapproved Homeopathic". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 17312-171-14, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 17312-0171-14, written without dashes as 17312017114. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 17312-0171-14, the first segment (17312) is the labeler code FDA assigned to TRP Company; the middle segment (0171) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (14) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by TRP Company. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
TRP Company is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose
🎯 Indications and Usage 60 words ▾

Uses • According to homeopathic indications these ingredients provide temporary relief from symptoms such as: • Muscle soreness • Fatigue • Nerve / soft tissue tenderness • Multiple tender points; after serious causes have been ruled out by a physician. * These statements are based upon traditional homeopathic practice. They have not been reviewed by the Food and Drug Administration.

⏱️ Dosage and Administration 91 words ▾

Directions Suitable for adults and children ages 2 and over. Children under the age of 2: Consult a physician before use. Dissolve entire tablet under tongue.

Do not chew or swallow whole. Take 1 tablet 3 times a day or as directed by a physician. Use up to 6 times a day as needed.

Take at least 10 minutes before or at least 10 minutes after eating or drinking. • Homeopathic remedies may not be effective for everyone. Individual results may vary. May take up to 60 days to see results.

⚠️ Warnings 32 words ▾

Warnings • A PHYSICIAN SHOULD ALWAYS BE CONSULTED TO RULE OUT SERIOUS CAUSES. • This product is intended to complement, not replace, standard medical treatment. • Initial worsening of symptoms may occur.

🧪 Active Ingredient 44 words ▾

Bryonia HPUS 6C, 12C, 18C Causticum HPUS 6C, 12C, 18C Hoitzia HPUS 6C, 12C, 18C Magnesia phosphorica HPUS 6C,12C,18C Pulsatilla HPUS 6C,12C,18C Rhus tox HPUS 6C,12C,18C Valeriana officinalis HPUS 6C,12C,18C HPUS indicates the active ingredients are in the Homeopathic Pharmacopoeia of the United States.

🧪 Inactive Ingredients 10 words ▾

Inactive Ingredients Advantol® 300, Lactose, Magnesium Stearate, Mannitol, Microcrystalline Cellulose.

🎯 Purpose 35 words ▾

Bryonia HPUS............................Difficulty moving, Stiff joints, acute soreness Causticum HPUS.......................Muscle and nerve soreness Hoitzia HPUS.............................Chronic discomfort, fatigue Magnesia phosphorica HPUS ...Cramping, Fatigue Pulsatilla HPUS .........................Migrating soreness Rhus tox HPUS..........................Soft tissue discomfort Valeriana officinalis HPUS..........Sleeplessness, Irritable bowels

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
← 17312-0170-14 · TRP 17312-0173-15 · TRP →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.